{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:13:55Z","timestamp":1792016035705,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017722","name":"Johannes und Frieda Marohn-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e15756","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:14:36Z","timestamp":1682338476000},"page":"e15756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Elexacaftor \u2013 Tezacaftor \u2013 Ivacaftor treatment improves systemic infection parameters and Pseudomonas aeruginosa colonization rate in patients with cystic fibrosis a monocentric observational study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-7181","authenticated-orcid":false,"given":"Alexander","family":"Schnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Ruppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Geppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tremel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Plattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-6174","authenticated-orcid":false,"given":"Joachim","family":"Woelfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-7168","authenticated-orcid":false,"given":"Andr\u00e9","family":"Hoerning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9358","key":"10.1016\/j.heliyon.2023.e15756_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15756_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"J. Cyst. Fibros."},{"issue":"33\u201334","key":"10.1016\/j.heliyon.2023.e15756_bib3","first-page":"564","article-title":"Cystic fibrosis","volume":"114","author":"Naehrig","year":"2017","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.heliyon.2023.e15756_bib4","series-title":"Patient Registry Annual Data Report","author":"Registry","year":"2021"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15756_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02288-2020","article-title":"Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study","volume":"58","author":"McKone","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e15756_bib6","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15756_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J. Transl. Med."},{"issue":"18","key":"10.1016\/j.heliyon.2023.e15756_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and theG551DMutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e15756_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10212","key":"10.1016\/j.heliyon.2023.e15756_bib10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15756_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00289-2020","article-title":"Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry","volume":"57","author":"Hall","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15756_bib12","first-page":"347","article-title":"[CF lung disease - a German S3 guideline: module 2: diagnostics and treatment in chronic infection with Pseudomonas aeruginosa]","volume":"72","author":"Schwarz","year":"2018","journal-title":"Pneumologie"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15756_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02774-2020","article-title":"Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator","volume":"57","author":"Laselva","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15756_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/jpm11070643","article-title":"A precision medicine approach to optimize modulator therapy for rare CFTR folding mutants","volume":"11","author":"Veit","year":"2021","journal-title":"J. Personalized Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15756_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15756_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e15756_bib17","series-title":"6 Monate Zulassung von Kaftrio\u00ae in Deutschland \u2013 erste Erfahrungen aus dem \u201ewahren Leben\u201c von Menschen mit CF","author":"Thomassen","year":"2022"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15756_bib18","article-title":"CFTR modulator therapy with lumacaftor\/ivacaftor alters plasma concentrations of lipid-soluble vitamins A and E in patients with cystic fibrosis","volume":"10","author":"Sommerburg","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15756_bib19","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.21037\/jtd.2018.07.47","article-title":"Application of albumin\/globulin ratio in elderly patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"10","author":"Qin","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.heliyon.2023.e15756_bib20","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.2147\/JIR.S335671","article-title":"Albumin\/Globulin Ratio as Yin\u2013Yang in rheumatoid arthritis and its correlation to inflamm-aging cytokines","volume":"14","author":"Chen","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15756_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2011-0399RT","article-title":"Immune responses in cystic fibrosis","volume":"46","author":"Ratner","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15756_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-019-1103-1","article-title":"CFTR regulates B cell activation and lymphoid follicle development","volume":"20","author":"Polverino","year":"2019","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15756_bib23","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.3390\/ijms21072398","article-title":"Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi\u00ae) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells","volume":"21","author":"Favia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15756_bib24","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.1800076","article-title":"Dysregulated calcium homeostasis in cystic fibrosis neutrophils leads to deficient antimicrobial responses","volume":"201","author":"Robledo-Avila","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15756_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2015.02.010","article-title":"Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor","volume":"15","author":"Bratcher","year":"2016","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15756_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15756_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1513\/AnnalsATS.202008-1054OC","article-title":"Effects of Lumacaftor\u2013Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis","volume":"18","author":"Graeber","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15756_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chest.2017.10.005","article-title":"CORK study in cystic fibrosis","volume":"153","author":"Ronan","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15756_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jcf.2021.11.003","article-title":"A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung","volume":"21","author":"Sosinski","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15756_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cid\/ciu944","article-title":"Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor","volume":"60","author":"Heltshe","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15756_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00185-2021","article-title":"Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration","volume":"59","author":"Morrison","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15756_bib32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/rccm.201407-1381OC","article-title":"Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection","volume":"191","author":"Hector","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15756_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.201206-1150OC","article-title":"A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection","volume":"187","author":"Tiringer","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023029638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023029638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:23:14Z","timestamp":1773397394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023029638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405844023029638"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15756","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor \u2013 Tezacaftor \u2013 Ivacaftor treatment improves systemic infection parameters and Pseudomonas aeruginosa colonization rate in patients with cystic fibrosis a monocentric observational study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15756"}}